Refine by
Stemline Pediatric Patients Equipment & Supplies
1 equipment items found
by:Stemline Therapeutics, Inc. based inNew York, NEW YORK (USA)
ELZONRIS was approved by the US Food and Drug Administration (FDA) on December 21, 2018, for the treatment of adult and pediatric patients, 2 years and older, with blastic plasmacytoid dendritic cell neoplasm (BPDCN). In January 2019, a marketing authorization application (MAA) for ELZONRIS for the treatment of patients with BPDCN was submitted ...